Engineering the regulatory pathways of a replicating oncolytic adenovirus enhances selective destruction of tumor cells.
References
Ramachandra, M. et al. Nat. Biotechnol. 19, 1035–1041 (2001).
Bischoff, J. et al. Science 274, 373–376 (1996).
Khuri, F.R. et al. Nat. Med. 6, 879–885 (2000).
Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M. & zur Hausen, H. J. Virol. 72, 9470–9478 (1998).
Kirn, D., Martuza, R.L. & Zwiebel, J. Nat. Med. 7, 781–787 (2001).
Alemany, R., Balague, C. & Curiel, D.T. Nat. Biotechnol. 18, 723–727 (2000).
Logg, C.R., Tai, C.K., Logg, A., Anderson, W.F. & Kasahara, N. Hum. Gene Ther. 12, 921–932 (2001).
Grote, D. et al. Blood 97, 3746–3754 (2001).
Peng, K-W. et al. Blood 98, 2002–2007 (2001).
Vile, R.G., Russell, S.J. & Lemoine, N.R. Gene Ther. 7, 2–8 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vile, R. Vironcology—not yet, but soon?. Nat Biotechnol 19, 1020–1022 (2001). https://doi.org/10.1038/nbt1101-1020
Issue Date:
DOI: https://doi.org/10.1038/nbt1101-1020
- Springer Nature America, Inc.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.